“Energy Armageddon Coming to America” and some updates on old favorites

We’ll be skipping almost all publishing next week, including the Friday File, as Stock Gumshoe closes down for a few days for vacation and redesign prep on the new and improved StockGumshoe.com — so I’ll try to make this one good enough to last a couple weeks for you! The new site, in case you’re [...]

“Cash In on China’s $608 Billion ‘Dragon’s Thirst’” (Chris Mayer)

Here’s the latest pitch from Chris Mayer for his Mayer’s Special Situations newsletter: “It’s the ONE resource more precious than oil, natural gas or gold. Without it, China’s growth — and the world’s — will likely come to a screeching halt. “Read on to discover the ONE tiny penny stock that has the breakthrough technology [...]

What is Frank Curzio’s “$10,000 Pill” Stock?

I suppose I should expect this by now — whenever Frank Curzio and the gang put out a teaser for Phase 1 Investor, which is the big-money newsletter from Stansberry & Associates ($5,000/year, though almost always “on sale” at $3,000 when they’re running promos), my inbox gushes like Spindletop. Didn’t matter if it was a [...]

Lombardi’s “How to Buy Gold and Get Silver for Free”

That sounds like an enticing headline, right? It’s getting to the point where, with gold at $1,900 an ounce, I’m going to have to start writing about gold mining stocks again — the teasers are piling up, and the querulous villagers are storming Gumshoe Castle and demanding answers. And since so many folks have not [...]

“How to Buy Apple for $12 a Share”

Louis Navellier is certainly not shy — he’s sent out several ads telling folks that the recent market turmoil is your opportunity to buy his favorite stocks (he’s a “growth” guy, so his faves are stocks with big revenue growth, earnings growth, momentum and upside surprises). I thought that might be a nice antidote — [...]

”They Stole $267 billion of King Saud’s Oil”

Your friendly neighborhood Gumshoe is still working feverishly on the new and improved StockGumshoe.com that we hope to be introducing in the weeks to come, so today we’re sharing an older article that originally appeared in the Irregulars-only Friday File. I’ve shortened the article to remove some of my blather, but it has not been [...]

“Bakken Oil Play You’ve Never Heard of … Stealth Trade of the Year”

The following is an excerpt from an article I published for the Stock Gumshoe Irregulars (our paid members) in the Friday File on July 1. It has NOT been updated, though I don’t believe there’s been official news from the company in the interim, and the ad it’s based on is running again with much [...]

“Rogue MIT Scientists’ Billion-Dollar Energy Cure”

These are the kind of teaser ads that always bring a smile to my face — top secret technology from “rogue” scientists, unknown breakthroughs that will change the face of the world and make us rich, that’s what teaser-land is all about! And certainly Nick Hodge knows that — all the publishers use the same [...]

“10 Best Stocks to Hold Forever” (part one)

Paul Tracy of StreetAuthority has been touting a special report he’s selling called “10 Best Stocks to Hold Forever” — he uses the example of the March 2009 market bottom as a great time to buy dominant, dividend-paying multinational companies … … and says that the recent market weakness again points at the opportunity provided [...]

“When the Bubble Bursts” Part Two

Yesterday I started looking into some Mark Skousen-teased ideas for ways to profit when the Chinese bubble bursts — today, as promised, we’ll steer the Thinkolator further along this same path and see if we can identify the other ideas he pitched. If you missed part one of our journey, you can see it here. [...]

“When the China Bubble Bursts: 6 Investments to Give You Profits PLUS Protection Through the Coming Crisis”

Today’s teasers come in from Mark Skousen, who edits the Forecasts & Strategies newsletter and has graced our pages a few times in the past — most recently when he touted Cubist Pharmaceuticals very aggressively as a “winning lottery ticket” and “superbug killer” (that one did quite well, thanks to both the FDA and a [...]

“Hunker Down with This 10.9% Yield!”

On days like this, we see a relatively small number of stock-pickers come out aggressively pushing a “buy this one stock” idea — I suppose that’s partly because newsletter editors like to see the market shake out before going out on a limb, and also probably partly because the way to make money in this [...]